cyclopenthiazide has been researched along with Hypertension in 60 studies
Cyclopenthiazide: Thiazide diuretic also used as an antihypertensive agent.
Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The antihypertensive efficacy and metabolic effects of cyclopenthiazide 125 micrograms were compared with cyclopenthiazide 500 micrograms in patients with non-insulin dependent diabetes and hypertension in a double blind, randomized crossover study." | 9.07 | The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension. ( Crawford, V; Johnston, GD; McVeigh, GE; Passmore, AP; Whitehead, EM, 1991) |
| "In a double-blind, placebo controlled, randomised parallel study we investigated the antihypertensive activity and metabolic adverse effects of three doses of cyclopenthiazide in 53 patients with mild hypertension." | 9.06 | Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension. ( Dulie, EB; Galloway, DB; Johnston, GD; McVeigh, GE; Ravenscroft, A, 1989) |
| "In a double blind placebo controlled randomised parallel study the antihypertensive activity and adverse biochemical effects of three doses of cyclopenthiazide were evaluated in patients with mild essential hypertension that had been recently diagnosed or was being treated with a single drug." | 9.06 | The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. ( Galloway, D; Johnston, D; McVeigh, G, 1988) |
| "Platelet free intracellular calcium levels were measured during a double-blind, placebo-controlled parallel study to investigate the antihypertensive activity of 50 micrograms, 125 micrograms, and 500 micrograms cyclopenthiazide, in mild essential hypertension." | 9.06 | Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension. ( Copeland, S; Johnston, D; McKellar, J; McVeigh, GE, 1988) |
| "25 mg cyclopenthiazide plus 600 mg potassium chloride ('Navidrex' K) in the treatment of mild to moderate essential hypertension." | 9.05 | Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension. ( Benton, KG; Weener, W; Whitehill, D; Whittington, JR; Wray, R; Wright, B, 1983) |
| "An open study was carried out in 641 patients with mild to moderate hypertension seen in general practice to assess the effectiveness of treatment with a timolol/hydrochlorothiazide/amiloride preparation compared with cyclopenthiazide/potassium." | 9.05 | Comparison of timolol/hydrochlorothiazide/amiloride ('Moducren') with cyclopenthiazide/potassium in mild to moderate hypertension. ( Arr, S; Parry, EE; Young, J, 1982) |
| "1 The blood pressure lowering effect of xipamide, a non-thiazide diuretic given for 6 weeks was compared in a randomised cross-over trial with that of cyclopenthiazide in 14 patients with essential hypertension." | 9.05 | Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium. ( Banks, RA; MacGregor, GA; Markandu, ND; Roulston, J, 1982) |
| "Two hundred and thirty-eight patients with essential hypertension from 39 general practice centres were treated in a double-blind trial with either oxprenolol 160 mg in a slow-release (SR) formulation with cyclopenthiazide 0,25 mg and potassium chloride 600 mg given once daily, or methyldopa 250 mg 3 times daily." | 9.04 | Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial. ( Levenstein, JH, 1978) |
| "Continuous intra-arterial blood pressure recording using the "Oxford" technique has been used to study the antihypertensive effects of oxprenolol taken three times daily in fully ambulatory patients with essential hypertension, outside hospital." | 7.66 | The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension. ( Altman, DG; Bala Subramanian, V; Mann, S; Millar-Craig, MW; Raftery, EB, 1983) |
| "In a study of 10 patients suffering from hypertension the results showed that combination treatment with prazosin, cyclopenthiazide and a beta-blocker produced a significant fall in blood pressure." | 7.65 | Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "We conducted an uncontrolled study of the efficacy of prazosin in the treatment of hypertension in 45 patients." | 7.65 | Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "The antihypertensive efficacy and metabolic effects of cyclopenthiazide 125 micrograms were compared with cyclopenthiazide 500 micrograms in patients with non-insulin dependent diabetes and hypertension in a double blind, randomized crossover study." | 5.07 | The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension. ( Crawford, V; Johnston, GD; McVeigh, GE; Passmore, AP; Whitehead, EM, 1991) |
| "In a double-blind, placebo controlled, randomised parallel study we investigated the antihypertensive activity and metabolic adverse effects of three doses of cyclopenthiazide in 53 patients with mild hypertension." | 5.06 | Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension. ( Dulie, EB; Galloway, DB; Johnston, GD; McVeigh, GE; Ravenscroft, A, 1989) |
| "In a double blind placebo controlled randomised parallel study the antihypertensive activity and adverse biochemical effects of three doses of cyclopenthiazide were evaluated in patients with mild essential hypertension that had been recently diagnosed or was being treated with a single drug." | 5.06 | The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide. ( Galloway, D; Johnston, D; McVeigh, G, 1988) |
| "Platelet free intracellular calcium levels were measured during a double-blind, placebo-controlled parallel study to investigate the antihypertensive activity of 50 micrograms, 125 micrograms, and 500 micrograms cyclopenthiazide, in mild essential hypertension." | 5.06 | Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension. ( Copeland, S; Johnston, D; McKellar, J; McVeigh, GE, 1988) |
| "25 mg cyclopenthiazide plus 600 mg potassium chloride ('Navidrex' K) in the treatment of mild to moderate essential hypertension." | 5.05 | Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension. ( Benton, KG; Weener, W; Whitehill, D; Whittington, JR; Wray, R; Wright, B, 1983) |
| "An open study was carried out in 641 patients with mild to moderate hypertension seen in general practice to assess the effectiveness of treatment with a timolol/hydrochlorothiazide/amiloride preparation compared with cyclopenthiazide/potassium." | 5.05 | Comparison of timolol/hydrochlorothiazide/amiloride ('Moducren') with cyclopenthiazide/potassium in mild to moderate hypertension. ( Arr, S; Parry, EE; Young, J, 1982) |
| "A double-blind crossover study was carried out to investigate the effects of cyclopenthiazide and oxprenolol on blood lipids in 20 previously untreated patients with mild to moderate hypertension." | 5.05 | Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study. ( Carruthers, M; Crisp, AJ; Ebbutt, AF; Hoffbrand, BI; Kennedy, PG, 1980) |
| "1 The blood pressure lowering effect of xipamide, a non-thiazide diuretic given for 6 weeks was compared in a randomised cross-over trial with that of cyclopenthiazide in 14 patients with essential hypertension." | 5.05 | Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium. ( Banks, RA; MacGregor, GA; Markandu, ND; Roulston, J, 1982) |
| "An open parallel study was carried out in general practice on 70 patients with uncomplicated mild to moderate hypertension to compare the hypotensive efficacy of hydrochlorothiazide/amiloride with that of cyclopenthiazide/potassium." | 5.05 | Do all diuretics have equal hypotensive efficacy? ( Gay, J; Grimshaw, JJ; Hossain, M; Jaffe, G, 1982) |
| "Twenty-eight previously untreated patients with essential hypertension were included in a randomized double-blind cross-over study comparing the results of treatment with the established combination of a thiazide and methyldopa (regimen A) with the combination of a beta-receptor blocker and hydralazine (regimen B)." | 5.04 | Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine. ( Hansen, M; Hansen, OP; Lindholm, J, 1977) |
| "Two hundred and thirty-eight patients with essential hypertension from 39 general practice centres were treated in a double-blind trial with either oxprenolol 160 mg in a slow-release (SR) formulation with cyclopenthiazide 0,25 mg and potassium chloride 600 mg given once daily, or methyldopa 250 mg 3 times daily." | 5.04 | Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial. ( Levenstein, JH, 1978) |
| "Continuous intra-arterial blood pressure recording using the "Oxford" technique has been used to study the antihypertensive effects of oxprenolol taken three times daily in fully ambulatory patients with essential hypertension, outside hospital." | 3.66 | The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension. ( Altman, DG; Bala Subramanian, V; Mann, S; Millar-Craig, MW; Raftery, EB, 1983) |
| "In patients with hypertension resistant to three or four drugs including a thiazide diuretic substitution of frusemide for the thiazide, or the addition of spironolactone, produced significant reductions in blood pressure and body weight." | 3.66 | Diuretic treatment of resistant hypertension. ( Freestone, S; Ramsay, LE; Silas, JH, 1980) |
| "A multicentre, open study of general practice patients with essential hypertension who were currently being treated with oxprenolol and cyclopenthiazide was undertaken in which the patients were transferred to Trasidrex for 12 weeks." | 3.66 | A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K. ( Ebbutt, AF; Elsdon-Dew, RW, 1979) |
| "Sixty-two patients with hypertension who were treated with a free combination of Slow Trasicor or Trasicor and Navidrex K were transferred to a fixed combination tablet, Trasidrex (slow oxprenolol 160 mg + cyclopenthiazide 0." | 3.66 | Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice. ( Ebbut, AF; Elsdon-Dew, RW; Murphy, JE, 1978) |
| "In a study of 10 patients suffering from hypertension the results showed that combination treatment with prazosin, cyclopenthiazide and a beta-blocker produced a significant fall in blood pressure." | 3.65 | Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "We conducted an uncontrolled study of the efficacy of prazosin in the treatment of hypertension in 45 patients." | 3.65 | Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension. ( Bhoola, R; Seedat, MA; Seedat, YK, 1977) |
| "This paper presents experience with the treatment of mild to moderate hypertension by means of a thiazide diuretic (cyclopenthiazide), a small dose of a beta adrenergic blocking agent (oxprenolol) and progressively increasing doses of a vasodilator (hydrallazine)." | 3.65 | Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension. ( Goble, AJ, 1975) |
| " With the radioinhibitor assay used in this study, a single elimination phase of cilazaprilat was evident, with a half-life (t1/2) of 2-3 h." | 2.67 | Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide. ( Conway, EL; Howes, LG; Jackson, B; Johnston, CI; Krum, H; Louis, WJ, 1992) |
| " The results from this study suggest that these compounds in their standard dosage range are useful and safe antihypertensive agents in older patients." | 2.65 | The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination. ( Forrest, WA, 1981) |
| "Oxprenolol was given as the first drug to Group 1, and cyclopenthiazide as the first drug to Group 2." | 2.64 | Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment. ( Davies, R; Payne, NN; Slater, JD, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 56 (93.33) | 18.7374 |
| 1990's | 4 (6.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CATTANEO, I | 1 |
| GIRALDI, A | 1 |
| MAINIERI, L | 1 |
| FOX, CA | 1 |
| GOTO, Y | 1 |
| TAKITSUKA, H | 1 |
| MURAKAMI, K | 1 |
| NAKAMURA, H | 1 |
| TOMITA, M | 1 |
| SUZUKI, T | 1 |
| UEDA, A | 1 |
| MINAKAWA, T | 1 |
| CHIAKI, A | 1 |
| MATSUZAKI, M | 1 |
| YOKOYAMA, H | 1 |
| TAKEDA, T | 1 |
| UCHIDA, E | 1 |
| YAGI, S | 1 |
| IZUKA, M | 1 |
| KURAMITSU, H | 1 |
| OHARA, Y | 1 |
| TOYOSHIMA, T | 1 |
| KANBARA, S | 1 |
| KAWAMURA, H | 1 |
| HAGA, I | 1 |
| OTSUKA, T | 1 |
| OKUGUCHI, T | 1 |
| NINOMIYA, H | 1 |
| CHIBA, F | 1 |
| SCHNIDER, U | 1 |
| DOBREANU-ENESCU, V | 2 |
| HARNAGEA, P | 2 |
| TEODORINI, S | 2 |
| MOLNER, C | 2 |
| KAUDE, J | 1 |
| KIMURA, N | 1 |
| TOGURA, O | 1 |
| TAKAJIRO, K | 1 |
| MURAKAMI, H | 1 |
| KITAMURA, K | 1 |
| OJI, A | 1 |
| FUKUMOTO, T | 1 |
| FUKAE, S | 1 |
| KAEDING, A | 1 |
| KLINKMANN, H | 1 |
| Forrest, WA | 6 |
| Wray, R | 1 |
| Benton, KG | 1 |
| Whitehill, D | 1 |
| Wright, B | 1 |
| Weener, W | 1 |
| Whittington, JR | 1 |
| Stannard, M | 2 |
| Cohen, M | 2 |
| Cybulska, I | 1 |
| Brym, E | 1 |
| Parry, EE | 1 |
| Young, J | 1 |
| Arr, S | 1 |
| Millar-Craig, MW | 1 |
| Mann, S | 1 |
| Bala Subramanian, V | 1 |
| Altman, DG | 1 |
| Raftery, EB | 1 |
| Waal-Manning, HJ | 4 |
| Crisp, AJ | 1 |
| Kennedy, PG | 1 |
| Hoffbrand, BI | 1 |
| Ebbutt, AF | 2 |
| Carruthers, M | 1 |
| Levenstein, JH | 3 |
| Elsdon-Dew, RW | 3 |
| Holden, E | 1 |
| Khan, AU | 1 |
| MacGregor, GA | 1 |
| Banks, RA | 1 |
| Markandu, ND | 1 |
| Roulston, J | 1 |
| Jaffe, G | 1 |
| Grimshaw, JJ | 1 |
| Gay, J | 1 |
| Hossain, M | 1 |
| Ballantyne, D | 1 |
| Ballantyne, FC | 1 |
| Ramsay, LE | 1 |
| Silas, JH | 1 |
| Freestone, S | 1 |
| Davies, R | 1 |
| Payne, NN | 1 |
| Slater, JD | 1 |
| Jackson, G | 1 |
| Pierscianowski, TA | 1 |
| Mahon, W | 1 |
| Condon, J | 1 |
| Bourke, JB | 1 |
| McIllmurray, MB | 1 |
| Mead, GM | 1 |
| Langman, MJ | 1 |
| Bolli, P | 2 |
| Simpson, FO | 3 |
| Louis, WJ | 2 |
| Christophidis, N | 1 |
| Brignell, M | 1 |
| Vijayasekaran, V | 1 |
| McNeil, J | 1 |
| Vajda, FJ | 1 |
| Kalowski, S | 1 |
| Hua, AS | 1 |
| Whitworth, JA | 1 |
| Kincaid-Smith, P | 1 |
| Gyntelberg, F | 1 |
| Jacobsen, K | 1 |
| Martlev, A | 1 |
| Backer, P | 1 |
| Hansen, M | 1 |
| Hansen, OP | 1 |
| Lindholm, J | 1 |
| Wood, AJ | 1 |
| Seedat, YK | 3 |
| Seedat, MA | 2 |
| Bhoola, R | 2 |
| Ebbut, AF | 1 |
| Murphy, JE | 1 |
| Krogsgaard, AR | 1 |
| Trap-Jensen, J | 1 |
| Hartling, O | 1 |
| Svendsen, TL | 1 |
| Goble, AJ | 1 |
| Krum, H | 1 |
| Jackson, B | 1 |
| Conway, EL | 1 |
| Howes, LG | 1 |
| Johnston, CI | 1 |
| Passmore, AP | 1 |
| Whitehead, EM | 1 |
| Crawford, V | 1 |
| McVeigh, GE | 4 |
| Johnston, GD | 3 |
| Kaplan, NM | 1 |
| Wilson, R | 1 |
| McDermott, BJ | 1 |
| Duffin, D | 1 |
| Logan, J | 1 |
| Marrott, PK | 1 |
| Pascucci, VL | 1 |
| Dulie, EB | 1 |
| Ravenscroft, A | 1 |
| Galloway, DB | 1 |
| McVeigh, G | 1 |
| Galloway, D | 1 |
| Johnston, D | 2 |
| Copeland, S | 1 |
| McKellar, J | 1 |
| Stewart, DE | 1 |
| Ikram, H | 1 |
| Espiner, EA | 1 |
| Nicholls, MG | 1 |
28 trials available for cyclopenthiazide and Hypertension
| Article | Year |
|---|---|
Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
Topics: Adolescent; Adult; Aged; Benzothiadiazines; Blood Pressure; Body Weight; Clinical Trials as Topic; C | 1983 |
[Evaluation of the hypotensive effect of slow-release Trasicor].
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Cyclopenthiazi | 1982 |
Comparison of timolol/hydrochlorothiazide/amiloride ('Moducren') with cyclopenthiazide/potassium in mild to moderate hypertension.
Topics: Adult; Aged; Amiloride; Antihypertensive Agents; Blood Pressure; Clinical Trials as Topic; Cyclopent | 1982 |
Oral diuretics and hypertension.
Topics: Administration, Oral; Cyclopenthiazide; Diuretics; Dose-Response Relationship, Drug; Drug Combinatio | 1982 |
Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
Topics: Cholesterol; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Method; Humans; Hyp | 1980 |
Oxprenolol slow-release with cyclopenthiazide KCl in the treatment of essential hypertension. A multicentre general practice study.
Topics: Adult; Aged; Blood Pressure; Circadian Rhythm; Clinical Trials as Topic; Cyclopenthiazide; Delayed-A | 1981 |
A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
Topics: Adult; Aged; Antihypertensive Agents; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Pre | 1981 |
The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
Topics: Aged; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Double-Bli | 1981 |
A study comparing indapamide with cyclopenthiazide in geriatric patients.
Topics: Aged; Antihypertensive Agents; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Female; Humans | 1981 |
The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
Topics: Adult; Aged; Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Dou | 1982 |
Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
Topics: Adult; Blood Glucose; Blood Pressure; Cyclopenthiazide; Diuretics; Female; Humans; Hypertension; Mal | 1982 |
Do all diuretics have equal hypotensive efficacy?
Topics: Adult; Aged; Amiloride; Blood Pressure; Cyclopenthiazide; Diuretics; Drug Combinations; Female; Huma | 1982 |
Beta adrenergic blockade and diuretic therapy in benign essential hypertension: A dynamic assessment.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cyclopenthiazide; Drug Therapy, Combination; Female; He | 1976 |
Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
Topics: Blood Pressure; Body Weight; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Drug Evaluation; | 1978 |
Hydrallazine with beta-blocker and diuretic in the treatment of hypertension. A double-blind crossover study.
Topics: Adult; Aged; Cyclopenthiazide; Double-Blind Method; Drug Therapy, Combination; Humans; Hydralazine; | 1979 |
[2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
Topics: Adult; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Drug Evaluation; Drug Therapy, Combina | 1977 |
Controlled clinical study on antihypertensive treatment with a diuretic and methyldopa compared with a beta-blocking agent and hydralazine.
Topics: Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Method; Drug Eva | 1977 |
Oxprenolol slow-release with cyclopenthiazide-KCl compared with methyldopa in the treatment of essential hypertension. A multicentre general practice trial.
Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Double-Blind Met | 1978 |
Studies on tienilic acid in hypertensive hyperuricaemic patients in Dunedin, New Zealand.
Topics: Aged; Allopurinol; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Drug Therapy, Combination; | 1979 |
One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs.
Topics: Alkaline Phosphatase; Amiloride; Aspartate Aminotransferases; Bilirubin; Blood Pressure; Clinical Tr | 1979 |
Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double-blind cross-over study with cyclopenthiazide.
Topics: Clinical Trials as Topic; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Dose-Response Re | 1976 |
Steady-state pharmacokinetics and pharmacodynamics of cilazapril in the presence and absence of cyclopenthiazide.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cilazapril; Cyclopenthiazide; Dose-R | 1992 |
The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension.
Topics: Adult; Aged; Blood Glucose; Cyclopenthiazide; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Doub | 1991 |
Low-dose cyclopenthiazide in the treatment of hypertension: a one-year community-based study.
Topics: Adult; Aged; Apolipoproteins; Blood Glucose; Cholesterol; Cyclopenthiazide; Drug Administration Sche | 1991 |
Antihypertensive therapy with indoramin: risk-benefit profile in clinical practice.
Topics: Adolescent; Adult; Aged; Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Female; Humans; | 1986 |
Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.
Topics: Apoproteins; Blood Glucose; Blood Pressure; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; D | 1989 |
The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
Topics: Aged; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Dose-Response Relationship, Drug; Doubl | 1988 |
Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension.
Topics: Blood Platelets; Blood Pressure; Calcium; Clinical Trials as Topic; Cyclopenthiazide; Diuretics; Dou | 1988 |
32 other studies available for cyclopenthiazide and Hypertension
| Article | Year |
|---|---|
[The association of cyclopenthiazide, new sulfonamide diuretic, with guanethidine in the treatment of arterial hypertension].
Topics: Antihypertensive Agents; Chlorothiazide; Cyclopenthiazide; Diuretics; Guanethidine; Hypertension; Su | 1961 |
Guanethidine and cyclopenthiazide in the treatment of hypertension.
Topics: Amidines; Chlorothiazide; Cyclopenthiazide; Guanethidine; Hypertension | 1962 |
[Combined therapy of Navidrex and Ismelin for hypertension].
Topics: Amidines; Chlorothiazide; Cyclopenthiazide; Guanethidine; Hypertension; Psychotherapy, Multiple | 1962 |
[Clinical studies on the diuretic and hypotensive effect of cyclopenthiazide (Navidrex)].
Topics: Biomedical Research; Cyclopenthiazide; Diuretics; Hypertension; Hypotension | 1962 |
[Combination of guanethidine and cyclopenthiazide in hypertension therapy].
Topics: Amidines; Cyclopenthiazide; Guanethidine; Hypertension | 1961 |
[On the use of cyclopenthiazide and guanethidine alone and in combination in hypertension].
Topics: Chlorothiazide; Cyclopenthiazide; Guanethidine; Humans; Hypertension | 1963 |
[Combined treatment of hypertension with guanethidine-chlorothiazide derivatives (Ismelin-Esidrex and Ismelin-Navidrex)].
Topics: Chlorothiazide; Cyclopenthiazide; Dexamethasone; Guanethidine; Humans; Hydrochlorothiazide; Hyperten | 1962 |
[Clinica, hemodynamic and electrocardiographic effects of prolonged treatment with guanethidine or with combined guanethidine and cyclopenthiazide in hypertensive disease].
Topics: Cyclopenthiazide; Electrocardiography; Guanethidine; Hemodynamics; Humans; Hypertension | 1963 |
[Clinical, hemodyamic and electrocardiographical effects of prolonged treatment with guanethidine or with guanethidine-cyclopenthiazide in hypertensive disease].
Topics: Benzothiadiazines; Cyclopenthiazide; Electrocardiography; Guanethidine; Humans; Hypertension | 1963 |
[Experiences in the treatment of hypertension with cyclopenthiazide in general practice].
Topics: Chlorothiazide; Cyclopenthiazide; Family Practice; General Practice; Hypertension | 1962 |
[Cyclopenthiazide therapy].
Topics: Chlorothiazide; Cyclopenthiazide; Edema; Hypertension | 1963 |
[ON CYCLOPENTHIAZIDE (AWD-DRESDEN) THERAPY].
Topics: Benzothiadiazines; Cyclopenthiazide; Diuretics; Drug Therapy; Edema; Heart Failure; Hyperglycemia; H | 1964 |
An open comparison between free and a fixed combination of diuretic and beta-blocker in the management of essential hypertension.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Cyclopenthiazide; Diuretics; Drug Combinations; Female; | 1980 |
Indoramin in the treatment of hypertension.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Cyclopenthiazide; Drug Combinations; Drug Therapy, | 1983 |
The effects of oxprenolol on ambulatory intra-arterial blood pressure in essential hypertension.
Topics: Adult; Aged; Blood Pressure; Circadian Rhythm; Cyclopenthiazide; Heart Rate; Humans; Hypertension; M | 1983 |
Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
Topics: Adult; Aged; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Drug Combinations; Family Pra | 1980 |
Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
Topics: Adult; Aged; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Double-Blind Method; Hemodyna | 1981 |
Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
Topics: Adult; Aged; Blood Pressure; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Dose-Response | 1980 |
Diuretic treatment of resistant hypertension.
Topics: Adult; Aged; Bendroflumethiazide; Body Weight; Cyclopenthiazide; Drug Resistance; Female; Furosemide | 1980 |
Inappropriate antihypertensive therapy in the elderly.
Topics: Age Factors; Aged; Antihypertensive Agents; Cyclopenthiazide; Drug Therapy, Combination; Humans; Hyp | 1976 |
Drug-associated primary acute pancreatitis.
Topics: Acute Disease; Aged; Cyclopenthiazide; Drug Therapy, Combination; Furosemide; Humans; Hypertension; | 1978 |
Labetalol: bioavailability, drug plasma levels, plasma renin and catecholamines in acute and chronic treatment of resistant hypertension.
Topics: Administration, Oral; Adult; Aged; Biological Availability; Chlorothiazide; Cyclopenthiazide; Dose-R | 1978 |
Oxprenolol plus cyclopenthiazide-KCl versus methyldopa in the treatment of hypertension.
Topics: Cyclopenthiazide; Diuretics; Humans; Hypertension; Methyldopa; Oxprenolol; Sodium Chloride Symporter | 1979 |
Oxprenolol plus cyclopenthiazide-kci versus methyldopa in the treatment of hypertension.
Topics: Cyclopenthiazide; Drug Evaluation; Hypertension; Methyldopa; Oxprenolol; Research Design | 1979 |
A multicentre study examining the substitution of Trasidrex for the free combination of Slow-Trasicor and Navidrex-K.
Topics: Antihypertensive Agents; Blood Pressure; Body Weight; Cyclopenthiazide; Delayed-Action Preparations; | 1979 |
Prazosin combined with thiazide diuretic and beta-blocker in the treatment of hypertension.
Topics: Blood Pressure; Cyclopenthiazide; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Pindol | 1977 |
Trasidrex (a fixed combination of slow Trasicor 16o mg and Navidrex 0.25mg) in the treatment of hypertension: a multicentre clinical trial in general practice.
Topics: Adult; Aged; Blood Pressure; Cyclopenthiazide; Diuretics; Drug Combinations; Female; Humans; Hyperte | 1978 |
Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
Topics: Adult; Aged; Cyclopenthiazide; Delayed-Action Preparations; Diuretics; Drug Therapy, Combination; Fa | 1978 |
Prazosin alone and combined with a thiazide diuretic in the treatment of hypertension.
Topics: Adult; Aged; Cyclopenthiazide; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; M | 1977 |
Diuretics, beta blockers and vasodilators. Dosage in mild and moderate hypertension.
Topics: Cyclopenthiazide; Diuretics; Drug Therapy, Combination; Humans; Hydralazine; Hypertension; Male; Mid | 1975 |
The case for low dose diuretic therapy.
Topics: Bendroflumethiazide; Cyclopenthiazide; Diuretics; Dose-Response Relationship, Drug; Humans; Hyperten | 1991 |
Arrhythmogenic potential of diuretic induced hypokalaemia in patients with mild hypertension and ischaemic heart disease.
Topics: Amiloride; Arrhythmias, Cardiac; Chlorthalidone; Coronary Disease; Cyclopenthiazide; Diuretics; Fema | 1985 |